Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

被引:9
|
作者
Heitel, Pascal [1 ,2 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England
[2] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany
来源
MOLECULES | 2023年 / 28卷 / 02期
关键词
heterobifunctional molecules; proximity-inducing chimeras; targeted protein modification; conditional protein degradation; INDUCED DEGRADATION; DRUG DISCOVERY; RECEPTOR; KNOCKDOWN; RECOGNITION; THERAPY; LIGANDS; PROTACS; TAG;
D O I
10.3390/molecules28020690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Posttranslational modifications (PTMs) play an important role in cell signaling and they are often deregulated in disease. This review addresses recent advances in the development of heterobifunctional small molecules that enable targeting or hijacking PTMs. This emerging field is spearheaded by proteolysis-targeting chimeras (PROTACs), that induce ubiquitination of their targets and, thus, tag them for degradation by the proteasome. Within the last decade, several improvements have been made to enhance spatiotemporal control of PROTAC-induced degradation as well as cell permeability. Inspired by the success story of PROTACs, additional concepts based on chimeric small molecules have emerged such as phosphatase-recruiting chimeras (PhoRCs). Herein, an overview of strategies causing (de-)phosphorylation, deubiquitination as well as acetylation is provided, and the opportunities and challenges of heterobifunctional molecules for drug discovery are highlighted. Although significant progress has been achieved, a plethora of PTMs have not yet been covered and PTM-inducing chimeras will be helpful tools for chemical biology and could even find application in pharmacotherapy.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Expanding the horizons of targeted protein degradation: A non-small molecule perspective
    Huang, Xiaowei
    Wu, Fengbo
    Ye, Jing
    Wang, Lian
    Wang, Xiaoyun
    Li, Xiang
    He, Gu
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (06) : 2402 - 2427
  • [22] Optimization of a Protein-Targeted Medicine into an RNA-Specific Small Molecule
    Meyer, Samantha M.
    Tanaka, Toru
    Taghavi, Amirhossein
    Baisden, Jared T.
    Grefe, Maison
    Disney, Matthew D.
    ACS CHEMICAL BIOLOGY, 2023, 18 (11) : 2336 - 2342
  • [23] Identification of a small molecule that induces targeted protein degradation of ADAR1
    Liu, Yuan
    Larsen, Mads B.
    Lin, Bo
    Kennerdell, Jason R.
    Alfaras, Irene
    Camarco, Daniel P.
    Tuncer, Ferhan
    Finkel, Toren
    Chen, Bill B.
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Targeted Small-Molecule Inhibitors of Protein Kinase B as Anticancer Agents
    Collins, Ian
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (01) : 32 - 50
  • [25] Targeted Degradation of IRAK4 Protein Via Heterobifunctional Small Molecules for Treatment of MYD88 Mutant Lymphoma
    Kelleher, Joseph
    Audoly, Laurent
    Campbell, Veronica
    Chen, Jesse
    Ji, Nan
    Kamadurai, Hari
    Li, Henry
    Loh, Christine
    Rong, Haojing
    Vigil, Dominico
    Weiss, Matt
    Yuan, Karen
    Zhang, Yi
    Mainolfi, Nello
    BLOOD, 2018, 132
  • [26] Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
    Schneekloth, Ashley R.
    Pucheault, Mathieu
    Tae, Hyun Seop
    Crews, Craig M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (22) : 5904 - 5908
  • [27] A Small Molecule Trifunctional Ligand for Fibroblast Activation Protein-a (FAP)-Targeted Theranostics
    Kelly, J. M.
    Ponnala, S.
    Jeitner, T. M.
    Nikolopoulou, A.
    Williams, C., Jr.
    Hu, B.
    Babich, J. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S169 - S169
  • [28] Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment
    Zhang, Peiyuan
    Liu, Xiaohui
    Abegg, Daniel
    Tanaka, Toru
    Tong, Yuquan
    Benhamou, Raphael I.
    Baisden, Jared
    Crynen, Gogce
    Meyer, Samantha M.
    Cameron, Michael D.
    Chatterjee, Arnab K.
    Adibekian, Alexander
    Childs-Disney, Jessica L.
    Disney, Matthew D.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (33) : 13044 - 13055
  • [29] Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
    Arter, Chris
    Trask, Luke
    Ward, Sarah
    Yeoh, Sharon
    Bayliss, Richard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (08)
  • [30] Nanoformulations of small molecule protein tyrosine kinases inhibitors potentiate targeted cancer therapy
    Yin, Yanlong
    Yuan, Xiao
    Gao, Huile
    Yang, Qian
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 573